Jianmin Pharmaceutical Group Co.,Ltd. Stock: price and insider trades · China
健民集团
No insider purchase over the last 90 days. The latest, by 黄芳晶父亲, was filed 29 Dec 2022.
Jianmin Pharmaceutical Group Co.,Ltd.: what insiders have been doing
This page follows insider dealings at Jianmin Pharmaceutical Group Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. No insider at Jianmin Pharmaceutical Group Co.,Ltd. has published a filing in the past twelve months. The most recent one dates from 4 April 2023.
The full history, which starts in 2022, counts 1 purchase against 6 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +32.5%Entry CN¥49.69 · Close at T+365 CN¥65.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 500 shares13.8% of flowA股XSHGSSE:173000006539018300
- 500 shares13.6% of flowA股XSHGSSE:173000006539018270
- 500 shares11.9% of flowA股XSHGSSE:173000006539018240
- 500 shares12.1% of flowA股XSHGSSE:173000006539018200
- 1,000 shares21.0% of flowA股XSHGSSE:173000006539018180
- 500 shares8.8% of flowA股XSHGSSE:173000006539018140Canonical exit: 29 Mar 2023 (T+90)
- 1,000 shares18.7% of flowA股XSHGSSE:173000006539018100
7 of 7 declarations
About Jianmin Pharmaceutical Group Co.,Ltd.
健民集团 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of medicines and pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
